# Modafinil for the Treatment of Fatigue in Lung Cancer V9.0

> **NCT00829322** · PHASE4 · COMPLETED · sponsor: **University of Oxford** · enrollment: 208 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Modafinil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00829322
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2013-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00829322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00829322, "Modafinil for the Treatment of Fatigue in Lung Cancer V9.0". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00829322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*